Brain Biomarkers of Response to Treatment for Apraxia of Speech
NCT ID: NCT02046941
Last Updated: 2019-08-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2014-03-01
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatments of Acquired Apraxia of Speech
NCT01483807
Studying Language With Brain Stimulation in Aphasia
NCT05660304
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
NCT03313011
Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia
NCT01163461
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
NCT02094014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Speech Production Treatment
This treatment employs a response-contingent hierarchy made up of verbal modeling/repetition, graphic cueing, integral stimulation, and articulatory placement instruction. The investigators chose this treatment for the following reasons: 1) rigor of development demonstrated across multiple studies, 2) large and predictable effects with published, quantified effect sizes, 3) a demonstrated pattern of generalization to untrained items, illustrating experimental control, 4) an established multi-modal stimulation protocol, and 5) use of repeated practice, which is associated with neural plasticity.
Speech Production Treatment
This treatment employs a response-contingent hierarchy made up of verbal modeling/repetition, graphic cueing, integral stimulation, and articulatory placement instruction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Speech Production Treatment
This treatment employs a response-contingent hierarchy made up of verbal modeling/repetition, graphic cueing, integral stimulation, and articulatory placement instruction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a history of a single left hemisphere stroke
* at least 1 year post-stroke
* at least 12 years of education
* pre-morbidly right-handed (Edinburgh Handedness Questionnaire)
* within normal limits on the Test of Non-Verbal Intelligence
Exclusion Criteria
* MRI contraindications
* other motor speech disorders (e.g., dysarthria)
* current or recent (\<2 months) speech/language therapy
* prior SPT
* pre-morbid history of speech/language disorders
* significant hearing disabilities (based on a pure-tone audiological screen at 35 dB HL at 500, 1K, and 2K Hz for at least one ear)
* aphasia severity resulting in \<30th percentile performance on the Porch Index of Communicative Ability-R
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juliana V. Baldo, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Northern California Health Care System, Mather, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Northern California Health Care System, Mather, CA
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C1532-I
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.